• Interstitial Lung Disease May Develop in Patients with Any AAV Subtype, Study Suggests
  • New Cases of AAV with Kidney Damage Reported in Hypertension Patients Using Hydralazine
  • ‘Rare Impact Awards’ Dinner Marks Orphan Drug Act and NORD at 35
  • #ECRD2018 – EU Must Do More for Rare Disease Patients, Eurordis Leaders Say
  • Cytokine Levels Can Distinguish Autoantibody Types in AAV Patients, Study Shows
  • Rituxan Better at Maintaining Long-term Remission in AAV Patients in Clinical Trial
  • Kidney Function in Patients with Severe Renal Disease May Be Helped by Longer Immunosuppressive Use, Study Suggests
  • New Patient-reported Outcomes Questionnaire for AAV Reliable and Sensitive, Study Says
  • Blood Cleaning Method Lowers Hospital Deaths in AAV Patients with Pulmonary Bleeding, Study Finds
  • ANCA Vasculitis May Develop in Patients Negative for ANCA Antibodies, Case Report Contends
  • #ECRD2018 – Patient Access and Collaboration Focus of Eurordis Meeting May 10-12
  • Vasculitis Foundation Awards $160,000 for 3 New Research Projects